Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Some evidence suggests GLP-1 medications may improve erectile function in men with type 2 diabetes and obesity through better glycaemic control, weight reduction, and improved vascular health
Anecdotally, they may seem to alleviate episodes in patients like Gardiner because of the weight loss, changes in diet, or by avoiding dietary triggers
Yet, thanks to thorough insurance support, many insured patients pay considerably less than the standard price in Salt Lake City
Key findings from this 48-week, dose-ranging study of 338 adults with obesity: Participants receiving the highest dose (12 mg weekly) lost an average of 24.2% of their body weight in 48 weeks At the 12 mg dose, 100% of participants lost at least 5% of their body weight Approximately 83% of participants on the highest dose lost 15% or more of body weight The weight loss trajectory had not plateaued at 48 weeks, suggesting even greater weight loss with continued treatment To put these numbers in context, here is how retatrutides Phase 2 data compares to the landmark trials of existing medications: The fact that retatrutide achieved the highest percentage of weight loss in the shortest timeframe is what has researchers and patients so excited
Wilson SK, Delk JR II
US$ 27.07
US$ 24.89
US$ 22.30
US$ 24.77
US$ 20.60
